Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioLongevity Labs is a health and biotechnology company focused on the development and distribution of longevity-enhancing nutraceuticals and supplements. The company leverages research in geroscience to formulate products that target cellular pathways associated with aging, such as NAD+ depletion and sirtuin activation. Their core product line includes high-purity compounds like NMN (Nicotinamide Mononucleotide), Resveratrol, and Spermidine, which are designed to support metabolic health and cellular repair. BioLongevity Labs emphasizes the use of third-party testing and clinical research to provide consumers with evidence-based solutions for healthspan extension. The company operates primarily in the direct-to-consumer market, bridging the gap between laboratory longevity research and accessible wellness protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioLongevity Labs.